Why the study?
Early detection of AF is crucial to prevent cardioembolic stroke, and wearable devices using photoplethysmography (PPG) have emerged as tools for continuous monitoring and screening.
This review summarizes the current state of photoplethysmography-based wearable devices for atrial fibrillation detection, highlighting signal processing techniques and clinical challenges.
Challenges limit immediate clinical adoption of PPG-based AF detection; leaves open optimal algorithms and validation pathways for future trials.
Atrial fibrillation (AF) is a cardiac rhythm disorder associated with increased morbidity and mortality. It is the leading risk factor for cardioembolic stroke and its early detection is crucial in both primary and secondary stroke prevention. Continuous monitoring of cardiac rhythm is today possible thanks to consumer-grade wearable devices, enabling transformative diagnostic and patient management tools. Such monitoring is possible using low-cost easy-to-implement optical sensors that today equip the majority of wearables. These sensors record blood volume variations-a technology known as photoplethysmography (PPG)-from which the heart rate and other physiological parameters can be extracted to inform about user activity, fitness, sleep, and health. Recently, new wearable devices were introduced as being capable of AF detection, evidenced by large prospective trials in some cases. Such devices would allow for early screening of AF and initiation of therapy to prevent stroke. This review is a summary of a body of work on AF detection using PPG. A thorough account of the signal processing, machine learning, and deep learning approaches used in these studies is presented, followed by a discussion of their limitations and challenges towards clinical applications.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: